Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL2530282 | 1.00 | THRB (0.38) | THRBTET2 | |
| Acetic Acid SCHEMBL29256055 | 0.88 | THRB (0.43) | THRB | |
| Acetic Acid SCHEMBL29256049 | 0.86 | THRB (0.39) | THRB | |
| Methacrylic Acid SCHEMBL28737039 | 0.85 | THRB (0.38) | THRB | |
| Methacrylic Acid SCHEMBL31316646 | 0.84 | THRB (0.50) | THRBTET2 | |
| Perflubutane SCHEMBL5248074 | 0.82 | THRB (0.46) | THRBTET2 | |
| SCHEMBL3145629 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL2378730 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL7886337 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL11588700 | 0.82 | LMNA (0.35) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6833419-B2 | Fluorine-modified comb polymers based on acryloydimethyltaurine acid | CLARIANT GMBH (DE) | 2004-12-21 | — | — | US | claimed |
| US-20040116634-A1 | Fluorine-modified comb polymers based on acryloydimethyltaurine acid | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-17 | — | — | US | claimed |
| US-8187581-B2 | Copolymers from acryloyldimethyltaurine or an acryloyldimethyltaurate, olefinically unsaturated, noncationic, crosslinking comonomer, olefinically unsaturated, cationic comonomer having oxygen, nitrogen, sulfur or phosphorus, silicon-containing component, macromonomer having oxygen, nitrogen, sulfur | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2012-05-29 | — | — | US | disclosed |
| US-8062630-B2 | Polymer from acryloyldimethyltaurine, olefinically unsaturated, cationic comonomer, unsaturated, noncationic, crosslinking comonomer, an unsaturated silicon containing comonomer, a crosslinking macromonomer; a thickener, bodying agent, emulsifier, dispersant and/or stabilizer | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2011-11-22 | — | — | US | disclosed |
| US-20110257016-A1 | Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-7943157-B2 | copolymer based on acryloxydimethyltaurine; water soluble, water swelling | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2011-05-17 | — | — | US | disclosed |
| US-7566763-B2 | Stable dispersion concentrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-07-28 | — | — | US | disclosed |
| US-20080207773-A1 | Cosmetic, pharmaceutical and dermatological products | CLARIANT GMBH (DE) | 2008-08-28 | — | — | US | disclosed |
| US-7399478-B2 | Cosmetic, pharmaceutical and dermatological products | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-07-15 | — | — | US | disclosed |
| US-7393520-B2 | Decorative cosmetic and dermatological products | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2008-07-01 | — | — | US | disclosed |
| US-20080107617-A1 | Surfactant-containing cosmetic, dermatological and pharmaceutical agents | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH | 2008-05-08 | — | — | US | disclosed |
| US-20040115149-A1 | Cosmetic, pharmaceutical and dermatological products containing an electrolyte | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-17 | — | — | US | disclosed |
| US-20040115148-A1 | Acid cosmetic, dermatological and pharmaceutical agents | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-17 | — | — | US | disclosed |
| US-20040115157-A1 | Cosmetic and dermatological hair-treatment agents | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-17 | — | — | US | disclosed |
| US-20040109838-A1 | Compositions containing copolymers based on acryloyldimethyl aminoethylsulfonic acid and synergistic additives | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-10 | — | — | US | disclosed |
| US-20040109836-A1 | Surfactant-free cosmetic, dermatological and pharmaceutical agents | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-10 | — | — | US | disclosed |
| US-20040109835-A1 | Cosmetic, pharmaceutical and dermatological products | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-06-10 | — | — | US | disclosed |
| US-20040096409-A1 | Comb copolymers of 2-acrylamido-2-methylpropanesulfonic acid or salts | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-05-20 | — | — | US | disclosed |
| US-20040091444-A1 | Decorative cosmetic and dermatological products | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2004-05-13 | — | — | US | disclosed |
| US-20030232028-A1 | Stable dispersion concentrates | CLARIANT GMBH | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040109835-A1 | Cosmetic, pharmaceutical and dermatological products | ATIC, FFAR3, TPMT | THRB 4539/4885TET2 1067/4885 |
| US-20040096409-A1 | Comb copolymers of 2-acrylamido-2-methylpropanesulfonic acid or salts | PAICS, MTHFD2, DIMT1 | THRB 3788/4885TET2 1018/4885 |
| US-20110257016-A1 | Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels | HSP90AA1, HSP90B1, HSPA1B | THRB 4426/4885TET2 4429/4885 |
| US-20040091444-A1 | Decorative cosmetic and dermatological products | CUTA, ESD, ATIC | THRB 4746/4885TET2 682/4885 |
| US-20040109838-A1 | Compositions containing copolymers based on acryloyldimethyl aminoethylsulfonic acid and synergistic additives | TPMT, ATIC, SLC6A12 | THRB 2704/4885TET2 3007/4885 |
| US-20040109836-A1 | Surfactant-free cosmetic, dermatological and pharmaceutical agents | FFAR3, SGMS1, SGMS2 | THRB 1850/4885TET2 2934/4885 |
| US-20030232028-A1 | Stable dispersion concentrates | FUS, CFD, C9 | THRB 4469/4885TET2 2003/4885 |
| US-20080107617-A1 | Surfactant-containing cosmetic, dermatological and pharmaceutical agents | SGMS1, SUCLG1, SGMS2 | THRB 4608/4885TET2 2714/4885 |
| US-20080207773-A1 | Cosmetic, pharmaceutical and dermatological products | TPMT, FFAR3, MTHFD2 | THRB 4490/4885TET2 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.